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Summary
Nonribosomal peptide synthetases are modular pro-
teins that operate in an assembly line fashion to
bind, modify, and link amino acids. In the E. coli entero-
bactin NRPS system, the EntE adenylation domain
catalyzes the transfer of a molecule of 2,3-dihydroxy-
benzoic acid to the pantetheine cofactor of EntB. We
present here the crystal structure of the EntB protein
that contains an N-terminal isochorismate lyase do-
main that functions in the synthesis of 2,3-dihydroxy-
benzoate and a C-terminal carrier protein domain.
Functional analysis showed that the EntB-EntE inter-
action was surprisingly tolerant of a number of point
mutations on the surface of EntB and EntE. Mutational
studies on EntE support our previous hypothesis that
members of the adenylate-forming family of enzymes
adopt two distinct conformations to catalyze the two-
step reactions.
Introduction
The nonribosomal peptide synthetases (NRPSs) are
a family of modular proteins that catalyze the enzymatic
synthesis of small peptides [1–3]. The secondary metab-
olites produced by the NRPS systems in bacteria and
fungi include peptides with antibiotic, immunosuppres-
sant, and anticancer activities, as well as some sidero-
phores. The enzymatic synthesis of the NRPS products
raises the possibility of engineering the NRPSs for the
generation of catalysts that may synthesize peptides
with novel activities [4].
Modular NRPSs contain multiple catalytic domains
joined in a single protein that may be tens of thousands
of residues in length. Usually, NRPSs contain one mod-
ule for each amino acid that is incorporated into the final
peptide. A minimal NRPS module contains two catalytic
domains and a carrier protein domain, onto which the
nascent peptide is attached during synthesis. The ad-
enylation domain first activates the substrate through
an adenylation reaction and then catalyzes the forma-
tion of a thioester between the acyl substrate and the
phosphopantetheine (PPant) cofactor on the carrier pro-
tein domain. A condensation domain serves to catalyze
peptide bond formation by transferring the amino acid
from an upstream domain to an amino acid located on
*Correspondence: gulick@hwi.buffalo.edua downstream domain. Additional catalytic domains
that exist in NRPSs include N-methylation and epimeri-
zation domains [1, 5]. The NRPS carrier protein domains
contain a conserved serine that is posttranslationally
modified by holo-ACP synthases with a PPant cofactor
[6] and are similar to acyl carrier proteins involved in
other cellular processes, including fatty acid biosynthe-
sis and metabolism and polyketide biosynthesis.
E. coli contains a single NRPS system that is used in
the synthesis of the siderophore enterobactin (Fig-
ure 1A). The enterobactin molecule contains three cop-
ies of a dipeptide of 2,3-dihydroxybenzoic acid (DHB)
and serine [7]. The serine molecules form a trilactone
ring between the carboxylate of one residue and the
side chain hydroxyl of the next. Produced and secreted
during iron-limiting conditions, the enterobactin mole-
cule chelates an Fe3+ ion and is then taken up into the
cell through the activity of the outer membrane transport
protein FepA [7].
The enzymes involved in enterobactin synthesis are
encoded by a six gene cluster (entA–F). The DHB mole-
cules are produced from chorismate by the activities of
EntA, EntB, and EntC (Figure 1B). EntC first catalyzes
the conversion of chorismate to isochorismate [8]. The
isochorismate lyase (ICL) domain of EntB hydrolyzes
the pyruvate group of isochorismate to form 2,3-dihy-
dro-2,3-dihydroxybenzoate [9], which is converted to
DHB by the activity of EntA, a 2,3-dihydro-2,3-dihydroxy-
benzoate dehydrogenase [10].
EntE, EntB, and EntF are NRPS enzymes that gener-
ate the enterobactin molecule from three molecules of
DHB and three molecules of serine, by using energy de-
rived from the hydrolysis of six ATP molecules. The EntE
protein contains an adenylation domain specific for DHB
(Figure 1C); EntE transfers the DHB molecule to the
PPant cofactor that is bound to the aryl carrier protein
(ArCP) domain of the EntB protein [11]. EntB is thus
a two-domain NRPS that contains both the ICL and
ArCP domains [12]. EntF contains the complete serine
module and a C-terminal domain that catalyzes the for-
mation of the trilactone ring [13, 14]. The enterobactin
NRPS system, therefore, contains only two modules
that work iteratively for the complete synthesis of the en-
terobactin molecule. The remaining protein of the enter-
obactin cluster, EntD, is a PPant transferase that adds
the cofactors to the carrier protein domains of EntB
and EntF [6, 12].
Structurally, the most well studied domain of the
NRPS systems is the adenylation domain. The adenyla-
tion domains are part of a larger family of adenylate-
forming enzymes that include firefly luciferase and
acyl-CoA synthetases [15, 16]. All members of this family
catalyze two-step reactions in which the first reaction is
an adenylation step resulting in the formation of an acyl-
AMP. NRPS adenylation domains and the acyl-CoA syn-
thetases catalyze the formation of a thioester with either
PPant or with CoA in the second half-reaction. In its sec-
ond half-reaction, luciferase catalyzes an oxidative de-
carboxylation that results in an activated molecule that
decomposes to emit light [17].
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adenylation domains PheA [18] and DhbE [19], and sev-
eral acyl- and aryl-CoA synthetases [20–23]. The en-
zymes contain a large N-terminal domain of 400–520
residues and a smaller C-terminal domain ofw120 res-
idues. On the basis of structural and biochemical work,
we have previously proposed [20, 21] that the members
of this family adopt one conformation to catalyze the ini-
tial adenylation reaction. The C-terminal domain then ro-
tates byw140º to adopt a second conformation that is
used to catalyze the second half-reaction. This confor-
mational change, which we term domain alternation, re-
configures a single active site to catalyze the two half-
reactions.
Figure 1. Enterobactin Synthesis
(A) Enterobactin consists of three DHB serine amides with ester
linkages between serine side chain hydroxyls and carboxylates.
(B) The synthesis of DHB catalyzed by the sequential activities of
EntC, the ICL domain of EntB, and EntA.
(C) The two-step reaction catalyzed by the EntE adenylation do-
main. The enzyme first catalyzes the formation of the DHB adenyl-
ate. In a second half-reaction, EntE transfers the DHB moiety to the
PPant cofactor of the EntB ArCP domain.We have determined the crystal structure of the EntB
protein and present here further insight into the activity
of the NRPS adenylation domains. By using the EntB
structure as well as structures of EntE homologs in ad-
enylate- and thioester-forming conformations, we iden-
tified residues near the potential recognition interfaces
of EntB and EntE. We have created a series of point mu-
tations in EntB and tested them through kinetic analyses
with EntE. We have also created a series of mutations in
the EntE adenylation domain. Our results demonstrate
that the EntE adenylation domain is remarkably tolerant
of the point mutations in the EntB protein, and that a
variety of single-residue replacements have little effect
on the EntE-EntB interaction. These results also support
the domain rotation proposal for adenylate-forming
enzymes.
Results
Structure Determination of EntB
Crystallization of EntB was achieved through initial
screening with sparse matrix conditions by using
a wide variety of PEG- and salt-based precipitants [24,
25]. The structure of the two-domain EntB protein was
determined by molecular replacement with PHASER
[26, 27]. The search model was a single domain of
the 207 residue 2-amino-2-deoxyisochorismate lyase
(PhzD) protein [28]. PhzD, involved in phenazine biosyn-
thesis, is 45.5% identical to the ICL domain of EntB. A
molecular replacement solution was found with a dimer
of ICL domains in the asymmetric unit. Gel filtration ex-
periments demonstrated that the EntB forms a dimer in
solution as well. Electron density for portions of the main
helices of the ArCP domain was initially visible in differ-
ence density maps, and the connecting loops became
apparent as model building and refinement proceeded.
Crystallographic and refinement data statistics are
shown in Table 1.
The final model for EntB contains 558 residues; sub-
unit A is missing the N-terminal 4 residues and the C-ter-
minal 2 residues, while subunit B is missing 3 residues
from each terminus. Several residues have disordered
side chains and have been modeled as alanines. Linking
the N-terminal ICL domain with the C-terminal ArCP do-
main is the 5 residue sequence Pro-Ala-Pro-Ile-Pro. This
extended peptide positions the C-terminal carrier pro-
tein domain away from the ICL domain (Figure 2A). The
N-terminal domains of the two subunits of EntB super-
impose with a root-mean-square (rms) deviation of
0.23 A˚. Greater variability is observed with the C-termi-
nal domain. The rms deviation derived from overlapping
the two C-terminal domains is 0.32 A˚; however, the C-
terminal domains of the two subunits adopt different
conformations relative to the N-terminal domain. The
difference in the orientation between the two C-terminal
domains isw23º.
The N-terminal domain of EntB contains a central six-
stranded parallel b sheet (Figure 2). On one side of the
sheet are three a helices that form the subunit interface
of the EntB dimer. On the opposite side of the sheet is
a long a helix at residues Pro51-Asn71. A short single-
turn helix caps the C-terminal ends of theb sheet. A small
pocket forms between the core of the ICL domain and an
interrupted helix at Asp85-Met94. The distal side of this
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ing subunit, and Leu90 and Leu91 of one subunit interact
with Trp24 and Tyr165 of the neighboring subunit of the
dimer. A second set of interactions occurs between
Met94 and Trp95 of one subunit and the methylene car-
bons of Lys21 and Arg196 of the neighboring subunit.
The ICL domain of the EntB protein is very similar to
PhzD (Figure 3). The ICL domain and the PhzD molecule
align with an rms deviation of 0.9 A˚2 over 195 Ca atoms.
A comparison of the structures of the two proteins
shows that there are two small loops that differ between
the two proteins. The first, at residues Leu47–Cys50, re-
sults from a 2 residue insertion in EntB. This region of the
protein isw15 A˚ from the active site; there do not appear
to be any long-range effects of this change, as the inner
sphere of residues between the active site and this loop
remains unchanged. The second structural difference
occurs at residues Pro97–Gln106 of EntB. This loop im-
mediately follows the interrupted helix described above
that forms one wall of the active site. This structural
change results in the movement of Gly98 of EntB in a di-
rection positioning it slightly closer to the isochorismate
ligand of PhzD. The distance from the Gly98 Ca position
to the isochorismate aryl carboxylate is reduced from
3.9 A˚ in PhzD to 3.5 A˚ in EntB (Figure 3B). This change
may reflect a difference between the liganded and unli-
ganded structures. The PhzD structure was solved
bound to isochorismate as well as in the unliganded
form. The unliganded protein, however, contains a for-
mate ion bound in the active site that approximates
the position of the aryl carboxylate of isochorismate.
Table 1. Crystallographic and Refinement Data
Resolution 2.3 A˚
Space group P212121
Unit cell a = 50.9 A˚, b = 82.3 A˚,
c = 164.7 A˚
Matthews coefficient 2.64 A˚3/Da
Rmerge
a 5.9% (32.7%)
Completenessa 95.7% (76.8%)
I/sa 18.1 (2.3)
Number of observations 115,010
Number of reflections 30,029
Resolution range 40.0–2.3 A˚
Rcryst
a 18.6% (25.2%)
Rfree
a 24.1% (32.2%)
Wilson B factor 47.8 A˚2
Average B factor, overall 45.0 A˚2
Average B factor, protein
(N-term, chain A)b
42.2 A˚2, 42.2 A˚2
Average B factor, protein
(C-term, chain A)b
53.9 A˚2, 55.1 A˚2
Average B factor, protein
(N-term, chain B)b
41.7 A˚2, 42.2 A˚2
Average B factor, protein
(C-term, chain B)b
52.8 A˚2, 52.0 A˚2
Average B factor, solvent
(number of molecules)
44.3 A˚2 (229)
Average B factor, metal
ions (number of ions)
51.7 A˚2 (10)
Average B factor, ethylene
glycol (number of atoms)
59.9 A˚2 (4)
Rms deviation bond
lengths, angles
0.011 A˚, 1.245º
a Values for the highest-resolution shell (2.42–2.3 A˚) are given in pa-
rentheses.
b Presented for main chain and side chain atoms, respectively.The ArCP domain of EntB is a typical acyl carrier pro-
tein domain consisting of four helices. The Ser245 resi-
due of EntB, which is the site of addition of the cofactor,
is positioned at the start of the second helix. The Ser245
residue is located on the ArCP face that points away
from the ICL domain and is directed into solvent
(Figure 2A). This location allows access of this site to
the cofactor and to the EntE and EntF proteins with
which it will interact. In the crystal lattice, the Ser245
side chain is positioned close to a symmetry-related
molecule, and no electron density is observed for the
PPant cofactor. Prior to structure solution by molecular
replacement, attempts were made, without success, to
grow crystals of selenomethionine (SeMet)-labeled
EntB. SeMet-labeled protein was produced by the met-
abolic inhibition method [29] in minimal media, which,
lacking sufficient iron, induced the EntD PPant transfer-
ase [30]. As the Ser245 side chain is in close proximity to
a neighboring molecule in the crystal lattice, the holo-
protein containing the PPant cofactor could not crystal-
lize under the current conditions in the crystal form ob-
served with the apo-protein.
A number of acyl, fatty acyl, and peptidyl carrier pro-
tein structures have been determined by crystallogra-
phy and NMR [31–42]. There is considerable structural
variation; however, nearly all structures contain the
four main helices. A long loop joins helices 1 and 2,
and the cofactor binding serine residue is located at
the start of helix 2. Helices 1, 2, and 4 are similar in length
and orientation, while helix 3 is shorter and nearly per-
pendicular to the other helices. A simple overlay of the
Ca position of the different structures shows differences
in the orientations of the helices and results in relatively
high rms deviations of w2.5 A˚ over the complete do-
mains; this largely results from differences in the orien-
tations of the main a helices. To best compare the struc-
tures of the different carrier protein domains, we used
the program PROMOTIF [43] to determine the angles
of interaction between different helices. For EntB, the
angles between the helices were very similar to the
values observed for the peptidyl carrier protein domain
of the TycC3 NRPS protein [31]. The orientations of the
helices show some consistency between three different
classes of carrier protein domains: NRPS PCP domains,
fatty acyl carrier protein domains, and ACP domains
used in polyketide synthesis (Table 2). The angles ob-
served between helices of the two NRPS proteins are
more similar to those of the fatty acyl carrier protein do-
mains than to the interhelical angles of the polyketide
domains. Representative carrier proteins are shown in
Figure 3C. We also compared the angles of the struc-
tures determined by crystallography with those deter-
mined by NMR and showed that the values did not cor-
relate with experimental method (Table 2). Although the
number of structures limits a full statistical correlation,
the NRPS carrier proteins are more similar with respect
to helical orientation to the acyl carrier proteins from pri-
mary metabolism than to the carrier protein domains in-
volved in polyketide secondary metabolism.
Functional Analysis of EntB and EntE Mutants
By using our structure of EntB and prior structures of
adenylate-forming enzymes [19–21] as a guide, we con-
structed point mutations in residues at the surfaces of
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(A) Ribbon diagram of the EntB dimer. The N-terminal ICL domains are shown with blue helices; the central sheet of the ICL domain is shown in
red. The C-terminal ArCP domains are shown in green. The position of the cofactor binding Ser245 residue is represented with the gold sphere.
(B) Representative electron density. The electron density was calculated with coefficients of the form 2Fo 2 Fc and was contoured at 1s.EntB (Figures 4A and 4B) and EntE (Figure 4C) and
tested these mutants for the intermolecular transfer of
DHB from EntE to the EntB ArCP domain. Three loops
(Leu225–Ser229, Ile239–Arg256, Asp261–Asn270) were
identified on the surface of the ArCP domain near the
PPant binding site of Ser245 (Figure 4B). Examination
of the 32 residues that formed the interaction loops of
EntB demonstrated that 10 of these residues were di-
rected into the core of the protein and were unlikely to
be involved in specific side chain interactions with
EntE. Of the remaining 22 residues, we chose 9 residues
for mutagenesis that might contribute to interactions
with EntE; these residues were more centrally located
near Ser245 and were also positioned where they might
introduce charge or hydrophobic contacts toward the
interface (Figure 4A). To determine if the residues
formed specific interactions across the EntB/EntE inter-
face, residues were replaced with amino acids that ex-
hibited significantly different biochemical properties.
It was first necessary to produce the holo-EntB mu-
tants and confirm that the mutations did not affect the
ability of EntD to attach the PPant cofactor on the
EntB mutants. We relied on the in vivo pantetheinylation
of EntB by producing protein in minimal media. We used
MALDI-TOF mass spectrometry to analyze cofactor
content. Initially, two samples of wild-type protein
were submitted, one purified from rich media and onepurified from minimal media (Table 3). The difference in
molecular weight between the two samples was 341.2
Da, representing the presence of the PPant cofactor
on the protein produced in minimal media. To gauge
the ability to use mass spectrometry as an analytical
tool, a 50:50 mixture of the two samples was analyzed.
The [M+2H]2+ peak clearly distinguished the two sam-
ples and showed equal peak heights. Although mass
spectrometry is not quantitative, we felt that this could
be used to provide a rough estimate of the degree of co-
factor addition. The remaining mutants were grown in
M9 and subjected to mass spectrometric analysis. The
cofactor was properly added by EntD to all mutants ex-
cept one (Table 3). The remaining mutant, D244R,
showed a mixture of apo- and holo-protein, with the
peak of the holo-protein about 40% the height of the
apo-protein peak. Three independent preparations of
the D244R mutant were performed, and all generated
the same result. This suggests that mutation of the
Asp244 residue reduces the recognition of EntB by the
EntD PPant transferase; however, a small fraction
(w35% of the total EntB D244R protein produced) was
still modified. In E. coliACP, a homologous D35C mutant
is also unable to be properly converted to the holo-ACP
[44].
We then tested the ability of EntE to recognize the
holo-EntB mutants and transfer the DHB molecule to
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(A) Ca superposition of EntB and PhzD. The EntB protein is shown in yellow, while the PhzD protein is shown in blue. Positioned in the active
site is a molecule of isochorismate that was cocrystallized with PhzD (PDB code: 1NF8).
(B) Active site superposition of the PhzD protein (blue) with the EntB ICL domain (yellow). The loop at residues 97–106 of EntB is shown near
the top of the figure. Note that the homolog of Asp37 in EntB is an aspartic acid in PhzD as well; however, this residue was mutated in the PhzD
crystallization study to trap the enzyme with isochorismate.
(C) Stereorepresentation of the ACP domains. The EntB ArCP domain (shown in blue) is superimposed on the frenolicin polyketide synthase
ACP (green, 1OR5) and the E. coli ACP (red, 1T8K). The yellow sphere is at Ser245 in EntB. The axes of the four main helices are shown for each
domain.the PPant cofactor of EntB by using a coupled AMP-for-
mation assay. The S245A mutant and the wild-type EntB
purified from cells grown in iron-rich media showed very
limited activity as substrates for EntE. We then mea-
sured specific activity by using a single concentration
of the mutant EntB proteins. The mutant enzymes all
showed detectable activity with EntE; several served
as better acceptor substrates than the wild-type EntB
(Table 3).
Surprisingly, none of the dramatic mutations that we
constructed hindered the specific activity; only two res-
idues (Asp240 and Asp263) showed reductions in activ-
ity. While the D244R mutant showed only 13% activity,this assay was performed with the mixture of apo- and
holo-protein and is thus difficult to interpret. We per-
formed additional kinetic analyses with a subset of the
mutant EntB enzymes that included the two mutant pro-
teins that had the lowest specific activity and one of the
mutants that showed elevated activity, F264E. Apparent
kinetic constants were determined at constant concen-
trations of DHB and ATP and varying concentrations of
the holo-EntB. As would be expected for residues lo-
cated at the surface that may impact the recognition of
EntB and EntE, there is only a minimal (less than 2-fold)
effect on kcat. In contrast, the two mutations with a mild
impact on relative specific activity show increases in KM.
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H1-H2 Angle H1-H4 Angle H2-H3 Angle H2-H4 Angle H3-H4 Angle
PKS (n = 3) 134.9 6 4.7 118.2 6 6.5 141.3 6 1.6 220.8 6 3.6 148.4 6 7.5
NRPS (n = 2) 141.8 6 0.8 132.9 6 5.0 113.4 6 2.3 224.2 6 11.5 128.5 6 1.6
ACP (n = 8) 141.8 6 15.1 134.9 6 15.4 126.2 6 13.1 223.5 6 9.9 137.2 6 13.7
NMR (n = 8) 138.1 6 15.7 132.7 6 17.3 131.0 6 16.0 221.9 6 9.5 133.0 6 13.7
X-ray (n = 5) 138.1 6 11.1 127.5 6 7.1 122.4 6 10.6 225.0 6 5.9 143.3 6 9.9
The average interhelical angles are listed for carrier proteins grouped either by experimental method or by biological function (PKS, polyketide
synthase; NRPS, NRPS acyl or peptidyl carrier protein domains; ACP, acyl or fatty acyl carrier proteins). A total of 13 proteins were used in the
analysis. These include three PKS ACP domains (1NQ4, oxytetracycline ACP from S. rimosus [39]; 1OR5, frenolicin ACP from S. roseofulvus [40];
2AF8, actinorhodin ACP from S. coelicolor [35]), two NRPS carrier protein domains (1DNY, tyrocidin PCP domain from TycC from B. brevis [31];
ENTB, E. coli protein presented here), and eight acyl carrier protein domains (1L0H, 1T8K, and 1ACP, three independently determined structures
of E. coli acyl carrier protein [32, 34, 38]; 1F80 and 1HY8, two independently determined structures ofB. subtilis acyl carrier protein [36, 37]; 1DV5,
D-alanyl carrier protein from L. casei [41]; 1KLP, acyl carrier protein from M. tuberculosis [42]; 1VKU, acyl carrier protein from T. maritima).Mutational Analysis of EntE
We have proposed that members of the adenylate-form-
ing family adopt two conformations to catalyze the two-
step reaction [20, 21]. Starting with the crystal structure
of DhbE [19], we created a model in which the C terminus
of DhbE is in the thioester-forming conformation ob-
served in the structure of acetyl-CoA synthetase bound
to adenosine-50-propylphosphate and CoA [21]. From
this model, several residues were identified that project
toward the surface of the DhbE protein in close proxim-
ity to the PPant binding tunnel. In the crystal structure of
DhbE, these residues are more than 20 A˚ away from the
active site in the adenylate bound conformation (Fig-
ure 4C). These residues were mutated to test for the abil-
ity to affect the EntB-EntE interaction.
EntE mutations made were R437D, K473D, R494D,
and a double mutant containing R437D and K473D. Nei-
ther the wild-type nor any of the EntE mutants showed
spontaneous hydrolysis of ATP to produce AMP in the
absence of an EntB thiol acceptor (data not shown). Im-
portantly, all four mutants were able to catalyze the ex-
change of radiolabeled pyrophosphate into ATP; thus,
all four mutants were competent to catalyze the adenyl-
ation reaction (Table 3). In assays of the complete thio-
ester-forming reaction, the K473D and R494D mutants
had near wild-type activity, while R437D and the double
mutant R437D/K473D were reduced to 10% and 3%
specific activity, respectively, with the wild-type EntB
substrate. These activity levels are comparable to the
activities with wild-type EntE and the Ser245 mutant of
EntB. Arg437 immediately precedes Gly438, a 100%
conserved residue that is located on a loop that projects
into the active site in the thioester-forming conformation
observed in Acs [21]. These results therefore support
domain alternation, as the ability of this mutation to af-
fect the catalytic activity of the thioester-forming reac-
tion specifically implies that this loop indeed rotates
into the active site for the catalysis of the second half-
reaction.
Discussion
We present here the structure of the two-domain NRPS
protein EntB containing an N-terminal ICL domain and
a C-terminal ArCP domain. The structure provides a
view of the ICL catalytic active site. The EntB ICL domain
is a member of a family of isochorismatase enzymes that
may also serve as targets for inhibitor design [45]. Therehas been recent interest in the development of inhibitors
of the enzymes involved in chorismate metabolism that
may serve as leads for antibiotic development [46–48].
Also, the structure of a multidomain NRPS suggests
how the domains are organized, and our structural and
functional studies can provide additional clues to the
interaction of NRPS domains.
The comparison of the ICL domain with the active site
of PhzD [28] demonstrates strong conservation of im-
portant residues. The catalytic aspartic acid (Asp37 in
EntB) is retained, as are the residues that form the
mostly hydrophobic binding pocket (Phe42, Trp95, and
Tyr126). Residues that interact with the aryl carboxylate
(Gln79 and Arg88) are conserved, as is Lys123, which is
positioned to interact with the pyruvate carboxylate. In-
deed, the only inner shell residue of the active site that
differs is the replacement of Val154 of PhzD with Ile155
in EntB (Figure 3B). Interestingly, this residue is located
near the C4 position of the isochorismate ligand of the
PhzD structure. The catalytic efficiency of PhzD is re-
duced by a factor of 50 with chorismate compared to
isochorismate [28]. In contrast, the EntB protein dis-
plays a 103-fold decrease in catalytic efficiency for cho-
rismate compared to isochorismate [9]. Our structural
results suggest that the specificity reflects the inability
of EntB to accommodate the hydroxyl at the C4 position
of chorismate because of the replacement of Val154 in
PhzD with Ile in EntB. Additional functional and struc-
tural studies of the ICL domain will further clarify the
roles of individual active site residues.
Prior structural studies on NRPS proteins have been
limited to single domains, either self-standing proteins
like the adenylation domain DhbE [19] and the conden-
sation domain VibH [49], or genetically truncated do-
mains such as the phenylalanine-activating domain of
GrsA [18], the PCP domain of TycC [31], and the cycliza-
tion/thioesterase domain of SrfA-C [50]. Although the
two domains of EntB do not interact functionally, EntB
serves as a suitable small model to demonstrate that
some multidomain NRPS proteins retain sufficient struc-
tural rigidity for crystallization.
EntB uses a proline-rich linker to join the two domains.
This peptide limits interactions between the two do-
mains and maintains the active site of the N-terminal
ICL domain and the PPant cofactor binding site of the
ArCP domain at w45 A˚ from each other. Given the ap-
parent functional and structural independence of these
ICL and ArCP regions of the protein, one could ask
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(A) Mutations constructed in the EntB ArCP domain. A stereorepresentation of the EntB ArCP domain is shown. Ser245 is shown with the yel-
low sphere at the Og position. The remaining residues chosen for mutagenesis are shown in stick representation and are labeled. Hydrophobic
residues are shown in blue, while charged or polar residues are shown in red.
(B) The sequence of the EntB ArCP domain is shown with locations of the four helices indicated. Highlighted in yellow are the three loops that
form the surface of the ArCP domain around the Ser245 cofactor attachment site. Residues located on these loops that are directed to the
center of the protein and therefore unlikely to be involved in interactions are black. The residues mutated in this study are shown in blue.
The residues located on surface loops with side chains directed into solvent that were not mutated are green.
(C) Ribbon diagram of the DhbE protein crystallized in the presence of the DHB adenylate [19] in the proposed adenylate-forming conforma-
tion. The adenylate, shown in yellow, is located between the N-terminal (blue) and C-terminal (green) domains. Homologs of the three EntE
residues mutated are shown. For two of the mutations, the residues are identical in DhbE and EntE (in parentheses); the remaining residue,
Arg471 of DhbE, is a lysine in EntE.why the two domains are expressed as a single protein.
Perhaps this represents an extreme level of coregulation
of these two elements in enterobactin synthesis. The
synthesis of DHB from chorismate involves three steps
catalyzed sequentially by EntC, EntB, and EntA. The re-action catalyzed by EntC is reversible; the Keq for the re-
action is 0.56 in favor of the chorismate-to-isochoris-
mate direction [8]. The ICL step catalyzed by EntB is
thus the committed step toward DHB production. By
combining the ICL and ArCP domains, nature has
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EntB Protein Expected MW Observed MWa Relative Specific Activityb
Wild-type 33,091.7 33,100 1.00 6 0.05
WT-rich media 32,750.3 (apo) 32,759 0.05 6 0.01
S245A 32,734.3 (apo) 32,726 0.02 6 0.01
D227R 33,132.6 33,119 3.64 6 0.35
I239D 33,093.4 33,093 2.68 6 0.13
D240R 33,132.6 33,121 0.80 6 0.11
D244R apoc 32,791.4 32,781 0.13 6 0.02
D244R holoc 33,132.6 33,123 —
R247E 33,064.4 33,057 2.15 6 0.02
M249E 33,089.4 33,092 1.04 6 0.07
D263R 33,132.6 33,117 0.66 6 0.01
F264E 33,073.4 33,070 3.15 6 0.26
K269E 33,092.4 33,090 2.42 6 0.37
EntB Protein EntE KM (EntB) (mM) EntE kcat (sec
21) EntE kcat/KM (sec
21 mM21)
Wild-type 23.3 6 4.4 5.94 6 0.25 0.26 6 0.05
D240R 181.5 6 14.0 9.54 6 0.33 0.05 6 0.01
D263R 64.8 6 13.2 7.48 6 0.63 0.12 6 0.03
F264E 31.8 6 5.1 10.30 6 0.19 0.32 6 0.05
EntE Mutant Relative EntE Specific Activity (Complete Reaction)b Relative PPi-Exchange Activityb
Wild-type 1.00 6 0.05 1.00 6 0.11
R437D 0.10 6 0.01 0.94 6 0.15
K473D 0.87 6 0.08 0.87 6 0.17
R494D 0.92 6 0.11 0.90 6 0.22
R437D/K473D 0.03 6 0.01 0.84 6 0.12
a Molecular weight was observed by MALDI-TOF Mass spectrometry as described in the Experimental Procedures.
b Activity was calculated for the EntE-catalyzed reactions by using the complete reaction (measuring AMP production with the coupled assay) or
the adenylation reaction by using PPi-exchange. Results are expressed relative to wild-type.
c Two peaks were observed in the MS analysis of the D244R mutant, one corresponding to the holo-protein and one corresponding to the apo-
protein. The relative kinetic activity represents the activity observed with the mixture of apo- and holo-proteins.evolved to ensure the availability of the EntB ArCP do-
main when DHB is produced.
A long-standing goal, with obvious technical chal-
lenges, is to determine the structure of even larger mul-
tidomain NRPSs. Until such studies are successful,
structures of individual domains will continue to provide
details that can be used in the generation of models for
the interaction of neighboring domains. The creation of
such models will benefit from the limitations imposed
by available structural and biochemical data. For exam-
ple, the generation of a model for the interaction of the
EntE adenylation domain and the EntB ArCP domain is
constrained by the lengths of linker peptides that occur
between fused adenylation and carrier protein domains.
To identify the linker region between the adenylation and
PCP domains, the C-terminal Ala536 of EntE was taken
as the C terminus of the adenylation domain, and
Ile211 of EntB was taken as the N-terminal residue of
the PCP domain. Alignments of multiple adenylation do-
main carrier protein domain sequences showed that the
linker between these two residues is as short as 6 resi-
dues. Assuming an extended conformation of this re-
gion of the protein, the distance between Ile211 of
EntB and Ala536 of EntE in the thioester-forming com-
plex is, at most, 20–25 A˚.
As efforts to engineer novel NRPS systems continue,
it will be necessary to understand how NRPS domains
interact sequentially during catalysis. Our results dem-
onstrate that the EntB-EntE interaction is remarkably
tolerant to the single point mutations that we have con-
structed near the Ser245 cofactor binding position. Of
the nine mutations generated in EntB, five show ele-vated specific activity when compared with wild-type
EntB. This observation that the EntB sequence is not op-
timized for interaction with EntE may reflect the evolu-
tionary demands placed on the carrier protein domains,
which must interact with multiple protein partners. Mu-
tations that result in elevated binding affinity between
EntB and EntE may not provide a sufficient selective ad-
vantage if they are detrimental to interactions between
EntB and either of its other partners, EntF or EntD. Alter-
natively, the carrier protein domains may have evolved
to interact with only moderate affinity with any one part-
ner as a mechanism to retain the ability to migrate from
one protein partner to the next.
Significance
NRPSs are involved in the synthesis of small peptides
that can have antibiotic, immunosuppressant, or other
activities. The modular nature of the NRPSs makes
them suitable targets for engineering through the
modification of substrate binding pockets or through
domain ormodule rearrangements. The ability to repo-
sition domains, however, requires an understanding
of the nature of the interactions between specific do-
mains to avoid the juxtaposition of incompatible do-
mains. The crystal structure of the EntB protein pro-
vides insight into the nature of an NRPS two-domain
protein and demonstrates that the ArCP domain pro-
trudes from the ICL domain in a way that enables it
to interact with EntE and the condensation domain of
EntF. Our functional analysis suggests that the nature
of the interaction of EntB with EntE is rather
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417promiscuous, and that multiple single-residue point
mutations have little effect on the ability of EntE to rec-
ognize EntB. Our structural results also demonstrate
that the NRPS carrier protein domains may share
more overall structural similarities with ACP domains
involved in fatty acid synthesis than with the ACP do-
mains of polyketide biosynthesis. The mutagenesis
studies presented here support the domain alternation
hypothesis, which suggests that adenylation domains
will undergo a 140º domain rotation to catalyze the two
sequential chemical steps. This feature, together with
consideration of the lengths of interdomain linkers,
will assist in the modeling of the interaction of adenyl-
ation domains with carrier protein domains in both
inter- and intramolecular transfers of acyl substrates.
Experimental Procedures
Cloning, Expression, and Purification of EntE
The entE gene was cloned from E. coli JM109 DNA by PCR. Tem-
plate DNA was prepared by boiling 10 ml of an overnight culture in
90 ml water for 5 min. The primers used for PCR were 50-CCAGTGCA
TATGAGCATTCCATTCACCCG-30 and 50-CCACTCGAGTCAGGCT
GATGCGCGTGAC-30. The 1.6 kB gene product was cloned initially
into pGEM7z and then subcloned into a modified pET15b plasmid
that contained a TEV protease site [51]. All sequences were con-
firmed by DNA sequencing. This plasmid was used for expression
in BL21(DE3) cells. Cultures of cells were grown to an OD600 of
w0.6 at 37ºC and were induced with 0.5 mM IPTG for 3 hr. Cells
were lysed by sonication in a buffer containing 40 mM HEPES (pH
7.5 at 4ºC), 150 mM KCl, 20 mM imidazole, and 0.2 mM tris-(carboxy-
ethyl)phosphine (TCEP). Protein was purified by metal chelate affin-
ity chromatography. The column was washed with 50 mM imidazole,
followed by elution of tagged EntE with the lysis buffer containing
300 mM imidazole. The purified protein was dialyzed into cleavage
buffer (50 mM N-2-hydroxyethylpiperizaine-N0-3-propanesulfonic
acid [HEPPS] [pH 8.0 at 4ºC], 150 mM NaCl, 0.5 mM EDTA, and
0.2 mM TCEP). TEV protease (w0.3 mg) was added to the tagged
protein and allowed to react overnight at 4ºC in the dialysis bag.
The cleaved protein was passed over a metal chelate column, and
the untagged protein was collected from the flowthrough. The final
protein was dialyzed into 10 mM HEPES (pH 7.5 at 4ºC), 0.2 mM
TCEP, and 1 mM NaN3. From 1 L of cells,w45 mg protein was ob-
tained. This protein was frozen by pipetting directly into liquid nitro-
gen and was stored at 280ºC.
Cloning and Expression of EntB
The PCR primers used to clone entB were 50-CCAGTGCATATGGC
TATTCCAAAATTACAG-30 and 50-CCACTCGAGTTATTTCACCTCGC
GGGAG-30. The amplified gene was cloned into pGEM7z and then
pET15bTEV. Protein expression in BL21(DE3) cells was induced
with 0.5 mM IPTG overnight at 16ºC. Purification was again obtained
by two metal chelate chromatography steps separated by removal
of the His tag with TEV. Lysis buffer (50 mM HEPES [pH 7.5 at
4ºC], 150 mM NaCl, 0.2 mM TCEP, 10 mM imidazole) and elution
buffer (50 mM HEPES [pH 7.5 at 4ºC], 150 mM NaCl, 0.2 mM
TCEP, 300 mM imidazole) were used for purification. The TEV cleav-
age buffer was as described for EntE. The final dialysis buffer con-
tained 20 mM HEPES (pH 7.5 at 4ºC), 50 mM NaCl, and 0.2 mM TCEP.
Expression of Holo-EntB
Attempts to grow crystals of SeMet-labeled protein, produced by
metabolic inhibition in M9 minimal media, were never successful.
Once the final structure was obtained by using crystals grown of na-
tive protein, it was discovered that Ser245 was clearly unmodified
with the PPant cofactor. We reasoned that production of SeMet pro-
tein by growth in minimal media induced the host ent operon, result-
ing in the production of the EntD PPant transferase. The presence of
the cofactor on Ser245 sterically hinders lattice packing and pro-
vides an explanation for why we were unable to crystallize the SeMet
protein. holo-EntB, used for functional assays, was produced bygrowing cells in M9 minimal media supplemented with 0.18% glu-
cose, 148 mM thiamine, and 50 mg/ml ampicillin. Reproducing the
protocol that we had used to make SeMet-labeled protein, an amino
acid cocktail was added to a final concentration of 27 mM lysine, 42
mM threonine, 30 mM phenylalanine, 19 mM leucine, 19 mM isoleucine,
21 mM valine, and 17 mM methionine 30 min prior to induction. The
purification was the same as for wild-type protein. EntB samples
were submitted to the Roswell Park Cancer Institute Proteomics Fa-
cility for mass spectrometry analysis with a Waters Micromass
MALDI Micro MX mass spectrometer with 10 mg/ml sinapinic acid
as the matrix. The molecular weight was calculated from the
[M+2H]2+ ions because of improved resolution.
Crystallization of EntB and Structure Determination
Crystals of EntB were grown at 14ºC by hanging drop vapor diffusion
with a precipitant containing 10%–15% methyl ether PEG 5000, 0.7–
0.9 M MgCl2, 10% ethylene glycol, and 50 mM HEPPS (pH 8.0). The
crystals tended to be highly anisotropic, and multiple additives were
tested to improve the diffraction. The best crystals were obtained by
transferring the crystals from mother liquor to solutions containing
CaCl2 instead of MgCl2. The crystals were simultaneously cryopro-
tected by increasing the concentration of ethylene glycol to 22%.
Crystals were soaked for 9 min in 15% MePEG5000, 0.75 M CaCl2,
11% ethylene glycol, 50 mM HEPPS (pH 8.0), and they were soaked
for 8 min in the same solution with 22% ethylene glycol. Diffraction
data were collected at 2170ºC by using a Rigaku RU-H3RHB rotat-
ing anode, Osmic Max-Flux confocal focusing mirrors, and an R-axis
IV image plate. Diffraction images were processed with MOSFILM
[52], merged with SCALA, and converted to structure factors with
TRUNCATE of the CCP4 software suite [53].
The EntB structure was determined by molecular replacement by
using a single subunit of the PhzD protein [28] (PDB code: 1NF9) as
a search model. The program PHASER [27] was used to identify the
location of the two molecules in the asymmetric unit. Refinement of
the initial solution with REFMAC resulted in a model with a crystallo-
graphic Rcryst of 38.3% (Rfree of 42.5%). Statistics for data collection
and refinement are presented in Table 1. Representative electron
density is shown in Figure 2B.
Mutagenesis of EntB and EntE
Site-directed mutagenesis was carried out by using the QuikChange
Mutagenesis Kit (Stratagene) and by following the manufacturer’s
protocol. Oligonucleotides were designed to contain the desired
point mutation plus additional silent mutations to validate the reac-
tion by using a restriction digest. PCR was performed under the fol-
lowing conditions: denaturation at 95ºC for 30 s, followed by 16 cy-
cles of denaturation at 95ºC for 30 s, annealing at 55ºC for 1 min, and
extension at 68ºC for 10 min. Plasmid DNA was screened for the in-
serted silent restriction change, and the entire coding region was se-
quenced to confirm the introduction of the desired mutation only.
Assay for Adenylation Activity of EntE with Wild-Type
or Mutant EntB Proteins
Specific activity was determined by using an NADH+ consumption
assay monitored at OD340. Standard assays contained 50 mM
HEPES buffer (pH 7.5), 5 mM MgCl2, 1 mM TCEP, 1 mM ATP,
2 mM DHB, 3 mM phosphoenolpyruvate, 4 U myokinase, 4.5 U pyru-
vate kinase, 6.5 U lactate dehydrogenase, and 250 mM NADH+. EntE
and EntB proteins were introduced into the reaction at 2 mM and
60 mM, respectively. Specific activity was calculated from the linear
disappearance of NADH+, monitored for 180 s or until the absor-
bance due to NADH+ reached a plateau (due to covalent modifica-
tion of all holo-EntB). Wild-type activity was 0.18 mmol/min/mg
EntE. To determine apparent kinetic constants, the EntB concentra-
tion was varied from 10 to 90 mM. The program DYNAFIT [54] was
used to determine kinetic constants from the initial velocities.
Pyrophosphate Exchange Assay
The pyrophosphate exchange assay was performed by using stan-
dard techniques [11, 15]. In this assay, EntE is allowed to catalyze
the initial adenylation half-reaction in the absence of a thiol acceptor
molecule; during the reverse reaction, radiolabeled PPi is incorpo-
rated into ATP. Specifically, 1.0 mM EntE was added to 2 mM ATP,
0.2 mM NaPPi, 50 mM HEPES (pH 8.0), 100 mM NaCl, 10 mM
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32P-PPi, and 5 mM DHB. Reactions (100 ml) were in-
cubated for 10 min at 37ºC, then quenched with 0.5 ml 1.2% char-
coal, 0.1 M unlabeled PPi, and 0.35 M perchloric acid. The charcoal
was pelleted, washed twice with 1 ml H2O, and resuspended in
0.5 ml H2O for scintillation counting. Five replicate assays were per-
formed for each protein; results were recorded as mmol radiolabeled
ATP incorporated per min per mg of enzyme. Wild-type activity was
210 mmol radiolabeled ATP produced per min per mg of EntE.
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